Fifteen new stocks made the Most Attractive list this month, while four new stocks joined the Most Dangerous list.
July Performance Recap
The Most Attractive Stocks (+9.3%) outperformed the S&P 500 (+4.0%) last month by 5.3%. The best performing large cap stock gained 28% and the best performing small cap stock was up 23%. Overall, 32 out of the 40 Most Attractive stocks outperformed the S&P 500.
The Most Dangerous Stocks (+7.8%) underperformed the S&P 500 (+4.0%) as a short portfolio last month by 3.8%. The best performing large cap short stock fell by 5% and the best performing small cap short stock fell by 3%. Overall, 12 out of the 32 Most Dangerous stocks outperformed the S&P 500 as shorts.
The Most Attractive/Most Dangerous Model Portfolios outperformed as an equal-weighted long/short portfolio by 1.5%.
The Most Attractive stocks have high and rising returns on invested capital (ROIC) and low price to economic book value ratios. Most Dangerous stocks have misleading earnings and long growth appreciation periods implied by their market valuations.
Most Attractive Stocks Feature for August: Paccar
Paccar Inc. is the featured stock from August’s Most Attractive Stocks Model Portfolio. I first made PACCAR Inc. a Long Idea in July 2020 and the stock remains undervalued.
Paccar has grown revenue by 6% compounded annually and net operating profit after tax (NOPAT) by 14% compounded annually since 2012. Paccar’s NOPAT margin increased from 7% in 2012 to 13% in the trailing twelve months (TTM), and invested capital turns rose from 2.5 to 2.7 over the same time. Rising NOPAT margins and invested capital turns drive Paccar’s return on invested capital (ROIC) from 16% in 2012 to 36% in the TTM.
Figure 1: Paccar’s Revenue and NOPAT Since 2012
Paccar Is Undervalued
At its current price of $85/share, PCAR has a price-to-economic book value (PEBV) ratio of 0.7. This ratio means the market expects Paccar’s NOPAT to permanently decline by 30%. This expectation seems overly pessimistic for a company that has grown NOPAT by 20% compounded annually since 2017 and 14% compounded annually since 2012.
Even if Paccar’s NOPAT margin falls to 8.5% (compared to 13% in the TTM and 10% in 2022) and the company’s revenue grows just 6% compounded annually through 2032, the stock would be worth $104/share today – a 22% upside. Should Paccar grow profits more in line with historical levels, the stock has even more upside.
Critical Details Found in Financial Filings by My Firm’s Robo-Analyst Technology
Below are specifics on the adjustments I made based on Robo-Analyst findings in Paccar’s 10-Qs and 10-Ks:
Income Statement: I made $212 million in adjustments, with a net effect of removing $130 million in non-operating income (1% of revenue).
Balance Sheet: I made $6.7 billion in adjustments to calculate invested capital with a net decrease of $4.5 billion. One of the most notable adjustments was $953 million in adjustments for other comprehensive income. This adjustment represents 6% of reported net assets.
Valuation: I made $6.0 billion in adjustments, with a net increase in shareholder value of $5.5 billion. The most notable adjustment was $5.0 billion in excess cash. This adjustment represents 11% of Paccar’s market value.
Most Dangerous Stocks Feature: Mueller Water Products
MWA
Mueller Water Products, in. (MWA) is the featured stock from August’s Most Dangerous Stocks Model Portfolio.
Mueller Water Products’ NOPAT has fallen from $113 million in 2019 to $96 million over the TTM, or 4% compounded annually. NOPAT margin has fallen from 12% in 2019 to 7% in the TTM and such falling NOPAT margins drive Mueller Water Products’ ROIC from 6.2% to 4.6% over the same time.
Mueller Water Products’ economic earnings, the true cash flows of the business, have fallen from $3 million in 2019 to -$62 million in the TTM. See Figure 2.
Figure 2: Mueller Water Products’ Economic vs. Reported Earnings: 2019 – TTM
MWA Provides Poor Risk/Reward
Despite its poor fundamentals, Mueller Water Products’ stock is priced for significant profit growth, and I believe the stock is overvalued.
To justify its current price of $14/share, Mueller Water Products must improve its NOPAT margin to 8% (2022 level, up from 7% over the TTM)) and grow revenue by 9% (well above 10-year CAGR of 2%) compounded annually through 2032. In this scenario, Mueller Water Products’ NOPAT grows 9% compounded annually through 2032 and would equal $236 million in that year, or over 2x its highest-ever NOPAT achieved in 2019. I think these expectations are overly optimistic.
Even if Mueller Water Products maintains its NOPAT margin at TTM levels of 7% and grows revenue 5% compounded annually through 2032, the stock would be worth no more than $8/share today – a 40% downside to the current stock price.
Each of these scenarios also assumes Mueller Water Products can grow revenue, NOPAT, and FCF without increasing working capital or fixed assets. This assumption is unlikely but allows me to create best case scenarios that demonstrate the high expectations embedded in the current valuation.
Critical Details Found in Financial Filings by My Firm’s Robo-Analyst Technology
Below are specifics on the adjustments I made based on Robo-Analyst findings in Mueller Water Products’ 10-Qs and 10-K:
Income Statement: I made $45 million in adjustments, with a net effect of removing $21 million in non-operating expenses (2% of revenue).
Balance Sheet: I made $1.0 billion in adjustments to calculate invested capital with a net increase of $727 million. One of the most notable adjustments was $804 million in asset write-downs. This adjustment represented 64% of reported net assets.
Valuation: I made $587 million in adjustments, with a net decrease to shareholder value of $433 million. The most notable adjustment to shareholder value was $80 million in net deferred tax liabilities. This adjustment represents 4% of Mueller Water Products’ market value.
Disclosure: David Trainer, Kyle Guske II, Hakan Salt, and Italo Mendon?a receive no compensation to write about any specific stock, style, or theme.
